Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies

Condition:   Thrombotic Microangiopathies Intervention:   Drug: Eculizumab administration Sponsor:   University Hospital, Rouen Not yet recruiting

Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials